ID
BSX icon

Integral Derivatives’s Boston Scientific BSX Stock Holding History

Integral Derivatives’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,300
Closed -$404K – 704
2017
Q4 		$404K Buy
16,300
+5,000
+44% +$138K 0.01% 775
2017
Q3 		$330K Sell
11,300
-60,100
-84% -$1.66M 0.01% 864
2017
Q2 		$1.98M Buy
71,400
+43,600
+157% +$1.16M 0.04% 311
2017
Q1 		$691K Buy
27,800
+7,700
+38% +$187K 0.01% 635
2016
Q4 		$435K Buy
+20,100
New +$439K 0.01% 767
2014
Q1 		– Sell
-73,800
Closed -$887K – 1317
2013
Q4 		$887K Buy
+73,800
New +$872K 0.01% 831

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Integral Derivatives's BSX Position: Q1 2014 in Review

Integral Derivatives sold out of Boston Scientific (BSX) in Q1 2014, closing a stake of 61,600 shares — an estimated $809K sold.

Integral Derivatives first reported a position in BSX in Q4 2013 and held it in 1 quarter. The position peaked at $740K in Q4 2013. 440 funds tracked by Wall St. Rank hold BSX as of Q1 2014.

  • Integral Derivatives reported no remaining Boston Scientific position as of Q1 2014 after selling out during the quarter.
  • Integral Derivatives sold 61,600 Boston Scientific shares in Q1 2014, an estimated $809K.
  • Integral Derivatives first reported a position in Boston Scientific in Q4 2013 and held it in 1 quarter.
  • Integral Derivatives's Boston Scientific position peaked at $740K in Q4 2013.
  • 440 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2014.

Based on Integral Derivatives's 13F filing for Q1 2014, filed 2 May 2014.